Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formic Acid SCHEMBL28274231 | 1.00 | — | — | |
| Formic Acid SCHEMBL5818354 | 0.96 | LMNA (0.38) | LMNATSHRCA1CA2CA9 | |
| SCHEMBL28293011 | 0.82 | — | — | |
| Bicarbonate SCHEMBL27856188 | 0.82 | — | — | |
| SCHEMBL28143828 | 0.82 | — | — | |
| Bicarbonate SCHEMBL10451074 | 0.80 | CA1 (0.56) | LMNATSHRCA1CA2CA9 | |
| Bicarbonate SCHEMBL5154473 | 0.80 | — | — | |
| SCHEMBL2414 | 0.80 | — | — | |
| Formic Acid SCHEMBL741409 | 0.80 | — | — | |
| Oxalic Acid SCHEMBL1333025 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0658629-A1 | Process for preparation of polyol fatty acid ester and glyceride mixture obtained | Kao Corporation (JP) | 1995-06-21 | — | — | EP | claimed |
| EP-0319126-A2 | Process for preparation of polyol fatty acid ester and glyceride mixture obtained | Kao Corporation (JP) | 1989-06-07 | — | — | EP | claimed |
| US-4668763-A | PRESSURE SENSITIVE ADHESIVES | DYNAMIT NOBEL AG (DE) | 1987-05-26 | — | — | US | claimed |
| JP-7076670-A | — | — | None | — | — | JP | disclosed |
| US-12629324-B2 | Aqueous compositions comprising 6-undecanol-esters | EVONIK OPERATIONS GMBH (DE) | 2026-05-19 | — | — | US | disclosed |
| US-20240122831-A1 | AQUEOUS COMPOSITIONS COMPRISING 6-UNDECANOL-ESTERS | EVONIK OPERATIONS GMBH (DE) | 2024-04-18 | — | — | US | disclosed |
| EP-4294785-A1 | AQUEOUS COMPOSITIONS COMPRISING 6-UNDECANOL-ESTERS | Evonik Operations GmbH (DE) | 2023-12-27 | — | — | EP | disclosed |
| EP-4253499-A2 | HYDROXYALDIMIN AND CURABLE POLYURETHANE COMPOSITION HAVING A LOW CONTENT OF MONOMER ISOCYANATES | Sika Technology AG (CH) | 2023-10-04 | — | — | EP | disclosed |
| EP-2441802-B1 | II-CONJUGATED POLYMER COMPOSITION | IDEMITSU KOSAN CO (JP) | 2023-07-12 | — | — | EP | disclosed |
| EP-3632898-B1 | EP4 ANTAGONIST | ONO PHARMACEUTICAL CO (JP) | 2023-07-12 | — | — | EP | disclosed |
| CN-113840885-B | Antifouling coating composition | 日东化成株式会社 | 2022-11-15 | — | — | CN | disclosed |
| US-4339611-A | BUTANOL, BUTANAL, COBALT, IODINE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-07-13 | — | — | US | disclosed |
| US-4339609-A | BUTANOL, BUTANAL, COBALT, IODINE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-07-13 | — | — | US | disclosed |
| US-4339608-A | BUTANOL AND BUTANAL, COBALT, IODINE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1982-07-13 | — | — | US | disclosed |
| US-4331597-A | AMOXYCILLIN DERIVATIVES | MEIJI SEIKA KAISHA, LTD. (JP) | 1982-05-25 | — | — | US | disclosed |
| US-4315053-A | Base coats covered by a clear lacquer coating and process for coating | BASF FARBEN & FASERN AG (DE) | 1982-02-09 | — | — | US | disclosed |
| US-4252703-A | PRODUCT OF EPOXY RESIN AND POLYAMINE OR KETIMINE, CROSSLINKING AGENT | HERBERTS GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1981-02-24 | — | — | US | disclosed |
| US-4241056-A | ANTIBIOTICS | BOEHRINGER INGELHEIM GMBH (DE) | 1980-12-23 | — | — | US | disclosed |
| US-4148989-A | TITANIUM CHELATE COMPOUNDS | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1979-04-10 | — | — | US | disclosed |
| US-4140728-A | POLYEPOXIDE COMPOUND AND TITANIUM OR ZIRCONIUM CHELATE CATALYST | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) | 1979-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629324-B2 | Aqueous compositions comprising 6-undecanol-esters | ELOVL6, SCD, ELOVL3 | LMNA 1208/4885TSHR 3668/4885CA1 3256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.